genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Artificial Intelligence
Putting COVID-19 on the ‘Map’
GEN Edge
Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
GEN Edge
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
GEN Edge
Top 15 Best-Selling Drugs of 2019
News
Coronavirus
COVID-19 and Cats: Bronx Zoo Tiger Tests Positive
Coronavirus
MERS Vaccine that Fully Protects Mice Used as Basis for Coronavirus…
News
Artificial Proteins Give Living Cells a Computational Upgrade
GlaxoSmithKline
GSK Invests $250M in Vir as Companies Partner on COVID-19 Candidates
News
J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration
Insights
All
Trends for 2020
Commentary
Understanding Glycans in COVID-19 Drug Design
Coronavirus
NYC Scientists Swab the Subway in Search of SARS-CoV-2
Artificial Intelligence
Artificial Intelligence Is Helping Biotech Get Real
April 2020 Vol. 40 No.4
Cell-Based Immunotherapies Do Battle With Solid Tumors
A-Lists
Gilead Sciences
Catching Up to Coronavirus: Top 60 Treatments in Development
GEN Edge
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Coronavirus
MERS Vaccine that Fully Protects Mice Used as Basis for Coronavirus…
News
Artificial Proteins Give Living Cells a Computational Upgrade
GlaxoSmithKline
GSK Invests $250M in Vir as Companies Partner on COVID-19 Candidates
News
J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration
Magazine
March 2020 Vol. 40 No. 3
Expanding the CRISPR Toolbox
Commentary
Strategies for Optimizing CRISPR-Cas9 Delivery into Hard-to-Transfect Cells
March 2020 Vol. 40 No. 3
RNA Silencing Finds Its Therapeutic Voice
March 2020 Vol. 40 No. 3
Genomic Medicine Identifies Reconcilable Differences
Commentary
Hasten Genomic Medicine’s Rise with Advanced Data Management
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Feel the Flow: Immune Cell Signaling Cascades Reveal Phenotype and Function
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
April 2020 Vol. 40 No.4
To Improve Protein Aggregation Assessments, Combine PCT and MMS
April 2020 Vol. 40 No.4
Protein Labeling Kit
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
GlaxoSmithKline
GlaxoSmithKline
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
GlaxoSmithKline
GSK Invests $250M in Vir as Companies Partner on COVID-19 Candidates
GlaxoSmithKline
GSK, Immatics Ink Up-to-$1B Cancer Immunotherapy Collaboration
GlaxoSmithKline
Gilead Partnering with China on Trial of Remdesivir as Coronavirus Treatment
GlaxoSmithKline
Merck Acquires TRPML1 Agonist Developer Calporta for Up to $576M
GlaxoSmithKline
GSK Completes $120M Manufacturing Expansion in Upper Merion, PA
GlaxoSmithKline
GSK Advances Arthritis Candidate into Phase III, Triggering €22M Milestone Payment...
GlaxoSmithKline
GSK Partners with CRISPR Pioneers Doudna, Weissman to Launch Laboratory for...
GlaxoSmithKline
Thermo Fisher to Acquire API Plant in Cork, Ireland from GSK
GlaxoSmithKline
GSK to Co-Develop Merck KGaA’s Cancer Immunotherapy Candidate M7824 in $4.2B...
GlaxoSmithKline
Orchard Therapeutics Plans 3 Approval Submissions, In-House Manufacturing by 2021
GlaxoSmithKline
GSK to Acquire PARP Inhibitor Developer Tesaro for $5.1B
GlaxoSmithKline
GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development
GlaxoSmithKline
GSK Sells Psoriasis/Dermatitis Candidate Tapinarof to Dermavant
GlaxoSmithKline
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
GlaxoSmithKline
GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug5_2014_56448122_DNAblue_NovelDiagnosticGenomic12114111424-324x160.jpg "GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development")
